Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Brief: Medexus Pharmaceuticals Sees Q4 Revenue Up 15 Percent

June 22 (Reuters) - Medexus Pharmaceuticals Inc  MDP.TO :
    * SEES Q4 REVENUE UP 15 PERCENT
    * DELIVERED TOTAL REVENUE OF $20.3 MILLION IN FISCAL Q4
2022, AN
INCREASE OF 15% COMPARED TO FISCAL Q4 2021
    * CASH AND CASH EQUIVALENTS OF $10.0 MILLION (WITH $11.2
MILLION
OF TOTAL AVAILABLE LIQUIDITY) AT END OF FISCAL Q4 2022
    * NET LOSS WAS $5.3 MILLION FOR FISCAL Q4 2022
    * Q4 REVENUE VIEW $18.5 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5F47fH 
Further company coverage:  MDP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Medexus Pharmaceuticals

See all news